外周血单个核细胞Toll样受体4/NOD样受体蛋白3信号通路在溃疡性结肠炎患者缓解期复发预测中的价值OA
Value of the Toll-like receptor 4/NOD-like receptor protein 3 signaling pathway in peripheral blood mononuclear cells in predicting relapse during remission in patients with ulcerative colitis
目的 探究外周血单个核细胞Toll样受体4(TLR4)/NOD样受体蛋白 3(NLRP3)信号通路在溃疡性结肠炎(UC)患者缓解期复发评估中的价值.方法 选取UC患者182例(开发组),经统一规范化治疗,达到临床缓解后纳入研究.患者于临床缓解后1 d采集外周血标本,检测外周血单个核细胞TLR4/NLRP3信号通路相关分子表达,并以此为基线指标.规律随访12个月,根据患者复发情况分为非复发组和复发组.比较2组一般资料、外周血单个核细胞TLR4、NLRP3水平.采用Logistic回归分析筛选UC复发的影响因素.采用受试者工作特征(ROC)曲线评估外周血TLR4、NLRP3对UC复发的预测价值.另以上述182例UC患者的年龄、性别为参考,同时兼顾疾病严重程度、病变范围、既往治疗史、病程、合并症、缓解期实验室指标及吸烟/饮酒史等指标,筛选出 93例与开发组在上述指标上具有可比性的患者作为外部验证组.结果 2组Mayo评分、肠壁厚度、浸润深度、肠外表现、粪便乳铁蛋白、粪便钙卫蛋白、红细胞沉降率、降钙素原、C反应蛋白比较,差异有统计学意义(P<0.05).复发组的TLR4、NLRP3高于非复发组,差异有统计学意义(P<0.05).Logistic回归分析显示,TLR4、NLRP3均与UC患者复发独立相关(P<0.05).TLR4、NLRP3联合预测UC复发的曲线下面积(AUC)为0.867,显著高于二者单独预测的AUC(P<0.05).在外部验证中,TLR4、NLRP3联合预测的AUC为0.856,与内部联合预测的AUC比较,差异无统计学意义(P>0.05).结论 UC缓解期患者TLR4、NLRP3高表达是其复发的独立影响因素,联合检测预测价值更高,可为预后风险分层提供参考,其临床指导意义需前瞻性研究进一步证实.
Objective To investigate the value of the Toll-like receptor 4(TLR4)/NOD-like re-ceptor protein 3(NLRP3)signaling pathway in peripheral blood mononuclear cells in evaluating re-lapse during remission in patients with ulcerative colitis(UC).Methods A total of 182 patients with UC(development group)were selected and received standardized treatment.After achieving clinical remission,they were included in the study.Peripheral blood samples were collected from the patients 1 day after clinical remission,and the expression levels of molecules related to the TLR4/NLRP3 signaling pathway in peripheral blood mononuclear cells were detected as baseline indicators.Patients were followed up regularly for 12 months and divided into non-relapse group and relapse group ac-cording to their relapse status.General information and the levels of TLR4 and NLRP3 in peripheral blood mononuclear cells were compared between the two groups.Logistic regression analysis was used to screen for factors influencing UC relapse.The receiver operating characteristic(ROC)curve was used to evaluate the predictive value of peripheral blood TLR4 and NLRP3 for UC relapse.Ad-ditionally,based on the age and gender of the above 182 UC patients,and taking into account fac-tors such as disease severity,lesion extent,previous treatment history,disease duration,comorbidi-ties,laboratory indicators during remission,and smoking/alcohol consumption history,93 patients with comparable indicators to the development group were selected as the external validation group.Results There were significant differences in the Mayo score,intestinal wall thickness,depth of infiltration,extraintestinal manifestations,fecal lactoferrin,fecal calprotectin,erythrocyte sedimen-tation rate,procalcitonin and C-reactive protein between the two groups(P<0.05).The levels of TLR4 and NLRP3 in the relapse group were higher than those in the non-relapse group,with a sta-tistically significant difference(P<0.05).Logistic regression analysis showed that both TLR4 and NLRP3 were independently associated with relapse in UC patients(P<0.05).The area under the curve(AUC)for the combined prediction of UC relapse by TLR4 and NLRP3 was 0.867,which was significantly higher than the AUCs for their individual predictions(P<0.05).In the external validation,the AUC for the combined prediction by TLR4 and NLRP3 was 0.856,with no significant difference compared to the AUC for the internal combined prediction(P>0.05).Conclusion High expression of TLR4 and NLRP3 in patients with UC during remission is an independent influencing factor for their relapse.Combined detection has a higher predictive value and can provide a refer-ence for prognostic risk stratification.Its clinical guiding significance requires further confirmation by prospective studies.
张静;苏莎莎;董晓斌
新疆医科大学第四附属医院/新疆医科大学附属中医医院脾胃病科,新疆乌鲁木齐,830000新疆医科大学第四附属医院/新疆医科大学附属中医医院脾胃病科,新疆乌鲁木齐,830000新疆医科大学第四附属医院/新疆医科大学附属中医医院脾胃病科,新疆乌鲁木齐,830000
医药卫生
溃疡性结肠炎缓解期Toll样受体4NOD样受体蛋白3复发预测价值生物标志物受试者工作特征曲线
ulcerative colitisremission periodToll-like receptor 4NOD-like receptor pro-tein 3relapsepredictive valuebiomarkerreceiver operating characteristic curve
《实用临床医药杂志》 2026 (9)
69-75,7
新疆维吾尔自治区自然科学基金资助项目(2022D01C810)
评论